Summary
Health surveillance in the work environment involves continuous biological monitoring and medical screening, with the purpose of primary and secondary prophylaxis of work-related diseases. Is this screening activity governed by a rationale based on knowledge of dangerous exposure and the availability of valid tests? In the USA, where health surveillance programmes are used extensively, a study has found screening activity to be associated more with plant size than wick relevant exposure. This study was done to elucidate the character and extent of use of health surveillance in the work environment in the EC countries with the aid of a questionnaire survey. The chief medical officers of the National Labour Inspectorates supplied information on substances covered by health surveillance programme in the EC member states, together with the legislative status and numbers of exposed workers. Belgium, France, Italy and the former Federal Republic of Germany made extensive use of health surveillance programmes in cases of known exposure to metals, organic solvents, carcinogenic and genotoxic substances, mineral dust, ionizing radiation, and biological agents. Denmark and Holland ran national programmes only for substances covered by EC directives, while England, Ireland, Spain, and Portugal comprised an intermediate user group. The result suggest that the use of health surveillance is related more to the national choice of standard regulatory instruments than to relevant exposure.
Similar content being viewed by others
References
Aitio A, Riihimaki V, Vainio H (eds) (1984) Biological monitoring and surveillance of workers exposed to chemicals, Hemisphere, Washington
Angerer J, Schaller KH (eds) (1988) Analyses of hazardous substances in biological materials. Methods for biological monitoring, vol 2. DFG Deutsche Forschungsgemeinschaft. VCH, Weinheim
Anonymous (1988) Berufsgenossenschaftliche Grundsätze für arbeitsmedizinische Vorsorgeuntersuchungen. Hautpverband der gewerblichen Berufsgenossenschafen e. V. Gentner, Stuttgart
Berlin A, Yodaiken RE, Henman BA (eds) (1984) Assessment of toxic agents at the work place. Martinus Nejhoff, Boston
Bernard A, Lauwerys R (1986) Present status and trends in biological monitoring of exposure to industrial chemicals. J Occup Med 28:558–562
Halperin WE, Ratcliffe J, Frazier TM, Wilson L, Becker SP, Schulte PA (1986) Medical screening in the workplace: proposed principles. J Occup Med 28:547–552
Lutsky I, Kalbfleish JH, Fink JN (1983) Occupational allergy to laboratory animals: employer practices. J Occup Med 25:372–376
McNeil B, Eddy DM (1982) The costs and effects of screening for cancer among asbestos-exposed workers. J Chron Dis 35:351–358
Millar JD (1986) Screening and monitoring: tools for prevention. J Occup Med 28:544–547
Rasmussen K, Lunde-Jensen P, Svane O (1989) Biological monitoring and medical screening in the workplace. The Commission of the European Communities, Directorate-General for Employment, Social Affairs and Education, Luxembourg
Rathcliffe JM, Halperin WE, Frazier TM, Sundin DS, Delaney L, Horning RW (1986) The prevalence of screening in industry: report from the National Institute of Occupational Safety and Health, National Occupational Hazard Survey. J Occup Med 28:906–912
Zielhuis RL, Henderson PT (1986) Definitions of monitoring activities and their relevance for the practice of occupational health. Int Arch Occup Environ Health 57:249–257
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rasmussen, K., Lunde-Jensen, P. & Svane, O. Biological monitoring and medical screening at the workplace in the EC countries. Int. Arch Occup Environ Heath 63, 347–352 (1991). https://doi.org/10.1007/BF00381586
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00381586